Therefore, it is reasonable to believe that ACEIs decreased angiotensin II levels by inhibiting angiotensin-converting enzyme activity, while ARBs inhibited angiogenesis and tumour cell proliferation by suppressing angiotensin II binding to the AT1 receptor to produce antiprostate cancer effects. Here, AGT is linked to neoplasm.